Sainsbury's and Morrisons have been taken to task for illegally advertising tobacco, while Fortnum & Mason makes plans to ...

GDS’s June insights covers Buffett’s legacy, Novo’s rebound, and Rivian’s rise. Click here to read the full note now.

Cancer of the appendix, the small pouch-like organ attached to the large intestine that supports the immune system, affects 1 ...

"A nausea medication or stool softener can mitigate these side effects but once you stop the GLP1 peptides, your appetite may ...

Plastic surgeon Dr Benjamin Wabwire explains the current landscape of clinical weight management and why deeper scrutiny is ...

After a lifetime of good fortune, the generation has become vulnerable at exactly the wrong moment.

WEIGHT loss jabs have been a godsend for people in the UK living with obesity. But despite 1.5 million people using the ...

As more people resort to a new generation of drugs to achieve the perfect body, Leah Hardy examines the latest warnings over ...

GLP-1 drugs such as Wegovy, Ozempic and Mounjaro are transforming weight loss and reshaping the food industry - driving ...

A study from Mass General Brigham and Harvard Medical School raises questions about a new class of weight loss drugs — and ...

Ozempic is FDA-approved for treating type 2 diabetes – but could it also help with other conditions like PCOS Read on to find ...

Louisiana is facing a significant obesity challenge, ranking fourth in the nation for obesity rates. As a result, many residents are turning to weight loss drugs like Ozempic and Wegovy.